AWA
GMAB icon

Aaron Wealth Advisors’s Genmab GMAB Stock Holding History

Aaron Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
10,431
+1,146
+12% +$30.5K 0.01% 590
2026
Q1 		$249K Buy
9,285
+1,375
+17% +$41.2K 0.01% 612
2025
Q4 		$244K Buy
7,910
+484
+7% +$15.1K 0.01% 618
2025
Q3 		$228K Buy
+7,426
New +$181K 0.01% 598
2022
Q2 		– Sell
-843
Closed -$30.5K – 445
2022
Q1 		$30.5K Buy
+843
New +$28.9K 0.01% 545

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aaron Wealth Advisors's GMAB Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Genmab (GMAB) stake by 12% in Q2 2026, buying an estimated $30.5K and bringing the position to 10,431 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #590.

Aaron Wealth Advisors first reported a position in GMAB in Q1 2022 and has held it in 5 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Aaron Wealth Advisors held 10,431 shares of Genmab worth $287K as of Q2 2026.
  • Aaron Wealth Advisors bought 1,146 Genmab shares in Q2 2026, an estimated $30.5K.
  • Genmab made up 0.01% of Aaron Wealth Advisors's portfolio in Q2 2026, its #590 holding.
  • Aaron Wealth Advisors first reported a position in Genmab in Q1 2022 and has held it in 5 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.